Wittman; Mark D.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wittman; Mark D..The latest application filed is for "isofuranone compounds useful as hpk1 inhibitors".
Company Profile
1.29.23
- Wittman; Mark D. - Hopkinton MA
- Wittman; Mark D. - Wallingford CT
- Wittman; Mark D - Wallingford CT
- Wittman; Mark D. - Waliingford CT
- WITTMAN, MARK D. - CHESHIRE CT
- Wittman; Mark D. - Hamden CT
Patent Activity
| Patent | Date |
|---|---|
| Isofuranone compounds useful as HPK1 inhibitors Grant 11,166,959 - Araujo , et al. November 9, 2 | 2021-11-09 |
| Isofuranone Compounds Useful As Hpk1 Inhibitors App 20200390776 - Araujo; Erika M.V. ; et al. | 2020-12-17 |
| Imidazo-pyridazine derivatives as casein kinase 1 .delta./ inhibitors Grant 9,956,220 - Velaparthi , et al. May 1, 2 | 2018-05-01 |
| Imidazo-pyridazine Derivatives As Casein Kinase 1 Delta/epsilon Inhibitors App 20170137427 - Velaparthi; Upender ; et al. | 2017-05-18 |
| Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors Grant 9,598,423 - Velaparthi , et al. March 21, 2 | 2017-03-21 |
| Substituted imidazoles as casein kinase 1 D/E inhibitors Grant 9,556,179 - Velaparthi , et al. January 31, 2 | 2017-01-31 |
| Substituted 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine Derivatives As Casein Kinase 1 D/e Inhibitors App 20160311824 - Velaparthi; Upender ; et al. | 2016-10-27 |
| Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors Grant 9,475,817 - Velaparthi , et al. October 25, 2 | 2016-10-25 |
| Novel Substituted Pyrazolo-piperazines As Casein Kinase 1 D/e Inhibitors App 20160122358 - Velaparthi; Upender ; et al. | 2016-05-05 |
| Substituted pyrazolo-piperazines as casein kinase 1 .delta./.epsilon. inhibitors Grant 9,273,058 - Velaparthi , et al. March 1, 2 | 2016-03-01 |
| Pyrazole Substituted Imidazopyrazines As Casein Kinase 1 D/e Inhibitors App 20150344480 - Velaparthi; Upender ; et al. | 2015-12-03 |
| Novel Substituted Imidazoles As Casein Kinase 1 D/e Inhibitors App 20150344481 - Velaparthi; Upender ; et al. | 2015-12-03 |
| Novel Substituted Pyrazolo-piperazines As Casein Kinase 1 D/e Inhibitors App 20150133428 - Velaparthi; Upender ; et al. | 2015-05-14 |
| Pyrrolotriazine kinase inhibitors Grant 8,592,579 - Wittman , et al. November 26, 2 | 2013-11-26 |
| Triazine kinase inhibitors Grant 8,415,340 - Velaparthi , et al. April 9, 2 | 2013-04-09 |
| Thiazolyl compounds useful as kinase inhibitors Grant 8,343,999 - Marinier , et al. January 1, 2 | 2013-01-01 |
| Pyrrolotriazine Kinase Inhibitors App 20120302747 - Wittman; Mark D. ; et al. | 2012-11-29 |
| Pyrrolotriazine kinase inhibitors Grant 8,263,765 - Wittman , et al. September 11, 2 | 2012-09-11 |
| Pyrrolotriazine kinase inhibitors Grant 8,198,438 - Sampognaro , et al. June 12, 2 | 2012-06-12 |
| Thiazolyl compounds useful as kinase inhibitors Grant 8,148,400 - Marinier , et al. April 3, 2 | 2012-04-03 |
| Pyrrolotriazine Kinase Inhibitors App 20110124623 - Wittman; Mark D. ; et al. | 2011-05-26 |
| Pyrrolotriazine kinase inhibitors Grant 7,879,855 - Wittman , et al. February 1, 2 | 2011-02-01 |
| Triazine Kinase Inhibitors App 20100197654 - Velaparthi; Upender ; et al. | 2010-08-05 |
| Thiazolyl Compounds Useful As Kinase Inhibitors App 20100120770 - Marinier; Anne ; et al. | 2010-05-13 |
| Pyrrolotriazine Kinase Inhibitors App 20100113454 - Sampognaro; Anthony J. ; et al. | 2010-05-06 |
| Thiazolyl Compounds Useful As Kinase Inhibitors App 20100048581 - Marinier; Anne ; et al. | 2010-02-25 |
| Pyrrolotriazine Kinase Inhibitors App 20090239838 - Wittman; Mark D. ; et al. | 2009-09-24 |
| Pyrrolotriazine kinase inhibitors Grant 7,534,792 - Wittman , et al. May 19, 2 | 2009-05-19 |
| Tyrosine kinase inhibitors Grant 7,470,696 - Beaulieu , et al. December 30, 2 | 2008-12-30 |
| Pyrrolotriazine Kinase Inhibitors App 20080009497 - Wittman; Mark D. ; et al. | 2008-01-10 |
| Benzimidazole C-2 heterocycles as kinase inhibitors Grant 7,312,215 - Beaulieu , et al. December 25, 2 | 2007-12-25 |
| Tyrosine kinase inhibitors Grant 7,232,826 - Velaparthi , et al. June 19, 2 | 2007-06-19 |
| Novel Tyrosine Kinase Inhibitors App 20070135443 - Beaulieu; Francis ; et al. | 2007-06-14 |
| Tyrosine kinase inhibitors Grant 7,223,757 - Wittman , et al. May 29, 2 | 2007-05-29 |
| Tyrosine kinase inhibitors Grant 7,189,716 - Beaulieu , et al. March 13, 2 | 2007-03-13 |
| Tyrosine kinase inhibitors Grant 7,081,454 - Wittman , et al. July 25, 2 | 2006-07-25 |
| Novel tyrosine kinase inhibitors App 20060079518 - Wittman; Mark D. ; et al. | 2006-04-13 |
| Benzimidazole C-2 heterocycles as kinase inhibitors App 20050054655 - Beaulieu, Francis ; et al. | 2005-03-10 |
| Novel tyrosine kinase inhibitors App 20040180897 - Beaulieu, Francis ; et al. | 2004-09-16 |
| Novel tyrosine kinase inhibitors App 20040092514 - Velaparthi, Upender ; et al. | 2004-05-13 |
| Novel tyrosine kinase inhibitors App 20040044203 - Wittman, Mark D. ; et al. | 2004-03-04 |
| Taxane anticancer agents App 20020016356 - Kadow, John F. ; et al. | 2002-02-07 |
| Phosphonooxymethyl Ethers Of Taxane Derivatives App 20010023255 - GOLIK, JERZY ; et al. | 2001-09-20 |
| 6-halo-or nitrate-substituted paclitaxels Grant 5,912,264 - Wittman , et al. June 15, 1 | 1999-06-15 |
| Phosphonooxymethyl ethers of taxane derivatives Grant 5,646,176 - Golik , et al. July 8, 1 | 1997-07-08 |
| Amino acid derivatives of paclitaxel Grant 5,489,589 - Wittman , et al. February 6, 1 | 1996-02-06 |
| Deoxy taxols Grant 5,478,854 - Farina , et al. December 26, 1 | 1995-12-26 |
| Conversion of amines to hydroxylamines Grant 5,412,082 - Wittman , et al. May 2, 1 | 1995-05-02 |
| Hybrid antitumor compounds containing a cyclic enediyne and a DNA-binder Grant 5,395,849 - Wittman , et al. March 7, 1 | 1995-03-07 |
| Cytotoxic bicyclo[7.3.1]tridec-4-ene-2,6-diyne compounds and process for the preparation thereof Grant 5,198,560 - Kadow , et al. March 30, 1 | 1993-03-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 